{"date":"2025-06-17","count":26,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6620-2025-06-17-2055-o55w4x","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"20:55:24","subject":"更正公告本公司訂定除息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-06-17 20:55，「更正公告本公司訂定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-06-17-2055-v1gwxu","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"20:55:07","subject":"公告本公司調整現金股利配息率","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-06-17 20:55，「公告本公司調整現金股利配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-06-17-1924-4yzujo","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"19:24:08","subject":"公告本公司訂定除息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-06-17 19:24，「公告本公司訂定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-06-17-1923-12t02f3","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"19:23:47","subject":"公告本公司第四屆薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-06-17 19:23，「公告本公司第四屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-06-17-1923-peusgi","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"19:23:23","subject":"公告本公司第四屆審計委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-06-17 19:23，「公告本公司第四屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-06-17-1923-9769qc","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"19:23:01","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-06-17 19:23，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-06-17-1922-1dhzh9t","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"19:22:42","subject":"公告本公司114年股東常會通過解除新任董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-06-17 19:22，「公告本公司114年股東常會通過解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-06-17-1922-bww4av","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"19:22:19","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-06-17 19:22，「公告本公司114年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-06-17-1921-ds864w","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"19:21:53","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-06-17 19:21，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-06-17-1846-1hqsogb","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"18:46:06","subject":"公告本公司調整配息率","clause":"第14款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-06-17 18:46，「公告本公司調整配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2025-06-17-1841-54swv6","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2025-06-17","time":"18:41:18","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2025-06-17 18:41，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2025-06-17-1840-1lzewkc","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2025-06-17","time":"18:40:53","subject":"公告本公司董事長及總經理辭任","clause":"第6款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2025-06-17 18:40，「公告本公司董事長及總經理辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2025-06-17-1827-14ztyfn","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"18:27:14","subject":"公告本公司董事長決定現金股利配息及資本公積發放現金基準日","clause":"第14款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2025-06-17 18:27，「公告本公司董事長決定現金股利配息及資本公積發放現金基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-06-17-1825-1l1yemv","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"18:25:37","subject":"有關進滿投資股份有限公司、進富投資股份有限公司、璽富投資股份有限公司、楊清宗及魏碧素等五人擬公開收購本公司普通股說明","clause":"第53款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-06-17 18:25，「有關進滿投資股份有限公司、進富投資股份有限公司、璽富投資股份有限公司、楊清宗及魏碧素等五人擬公開收購本公司普通股說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-06-17-1750-ds864w","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-17","time":"17:50:05","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-06-17 17:50，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-06-17-1724-xcja3i","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-06-17","time":"17:24:18","subject":"公告本公司114年06月17日股東常會之重要決議事項","clause":"第15款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-06-17 17:24，「公告本公司114年06月17日股東常會之重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-06-17-1717-gi3647","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-06-17","time":"17:17:42","subject":"公告本公司董事會決議買回庫藏股事宜","clause":"第41款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-06-17 17:17，「公告本公司董事會決議買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2025-06-17-1700-1v7xglv","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"17:00:03","subject":"代子公司醫鈦康(股)公司公告辦理減資、發行新股變更登記完成","clause":"第36款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：立康（6242），2025-06-17 17:00，「代子公司醫鈦康(股)公司公告辦理減資、發行新股變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-06-17-1630-rtvqgw","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-06-17","time":"16:30:02","subject":"公告本公司第1次買回庫藏股期間屆滿及執行情形。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-06-17 16:30，「公告本公司第1次買回庫藏股期間屆滿及執行情形。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-06-17-1559-5qkx7","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"15:59:48","subject":"本公司受邀參加元大證券舉辧之法人說明會。","clause":"第12款","fact_date":"2025-06-18","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-06-17 15:59，「本公司受邀參加元大證券舉辧之法人說明會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-17-1552-1hq46xz","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-17","time":"15:52:05","subject":"公告本公司上市掛牌首五個營業日穩定價格操作結果","clause":"第51款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-17 15:52，「公告本公司上市掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-06-17-1544-1goxxmu","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-06-17","time":"15:44:54","subject":"公告本公司實施庫藏股期間屆滿及執行情形","clause":"第41款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-06-17 15:44，「公告本公司實施庫藏股期間屆滿及執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-06-17-1455-tzaprt","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"14:55:00","subject":"公告本公司董事會決議買回本公司股份並辦理轉讓員工","clause":"第35款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-06-17 14:55，「公告本公司董事會決議買回本公司股份並辦理轉讓員工」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-06-17-1434-1mwk7sr","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-06-17","time":"14:34:40","subject":"公告調整本公司國內第一次私募無擔保轉換公司債轉換價格","clause":"第53款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-06-17 14:34，「公告調整本公司國內第一次私募無擔保轉換公司債轉換價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-06-17-1234-lj8b3k","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-06-17","time":"12:34:37","subject":"公告本公司114年股東會重要決議事項(更正年度)","clause":"第15款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-06-17 12:34，「公告本公司114年股東會重要決議事項(更正年度)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-06-17-1232-1gph43b","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-06-17","time":"12:32:59","subject":"公告本公司113年股東會重要決議事項","clause":"第15款","fact_date":"2025-06-17","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-06-17 12:32，「公告本公司113年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}